🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsSide Effects & ManagementJoint pain improvement vs new joint pain — a paradox on GLP-1

Joint pain improvement vs new joint pain — a paradox on GLP-1

Dr.RheumBOS Fri, May 1, 2026 at 12:22 AM 28 replies 752 viewsPage 1 of 6
Dr.RheumBOS
Member
567
2,345
Apr 2024
Boston, MA
May 1, 2026 at 12:22 AM#1

The nausea I get is not really nausea, it is an aversion. Food I want in the abstract becomes repellent in front of me, which no side-effect list describes.

Trial-level incidence runs roughly 20 to 25% for nausea at the higher dose tiers and 12 to 17% for diarrhoea, with most events mild to moderate and concentrated in the weeks after each escalation.

What I am trying to establish is what distinguishes the nausea you can titrate through from the nausea that means stop.

Happy to be told the question itself is wrong.

14 9pam_stl, wei_SG, cory_ATX and 11 others
Reply Quote Save Share Report
RetaRick_CA
VIP Member
2,012
9,876
Jan 2024
California
May 1, 2026 at 12:45 AM#2

This one has a reasonably settled answer, so here it is. Holding genuinely reduces total burden rather than redistributing it, because the gastric-emptying component adapts. Receptor-level tachyphylaxis to the delayed-emptying effect develops over weeks while the central appetite effect persists, so the same dose is materially more comfortable at week six than at week two. A slower ladder therefore reaches the same dose with less cumulative nausea, not the same nausea spread thinner.

Last edited: May 1, 2026 at 1:45 AM
13 8AmyNC_wife, SkepticalSean, Dr.CardioMD and 10 others
Reply Quote Save Share Report
patPC_UT
Member
212
890
Nov 2024
Park City, UT
May 1, 2026 at 1:08 AM#3
RetaRick_CA said:
Holding genuinely reduces total burden rather than redistributing it, because the gastric-emptying component adapts.

Agreed on adaptation, with a caveat: adaptation applies to gastric emptying and not to everything. If your problem is the aversion rather than the fullness, waiting does less, because the aversion is central and it is the mechanism working as intended.

12 7TomFromTexas, mike.trainer_LA, sarah_nash92 and 9 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
FranDenver
Member
267
1,123
Oct 2024
Denver, CO
May 1, 2026 at 1:31 AM#4
Dr.RheumBOS said:
The nausea I get is not really nausea, it is an aversion.

Can confirm the pattern Dr.RheumBOS describes. The line between titrate-through and stop is not severity, it is trajectory and what else is present. Nausea that peaks and improves within a week is the expected pattern. Nausea that is escalating, or that comes with severe upper-abdominal pain radiating to the back, or that prevents fluids for more than a day, is a different conversation and belongs with a clinician the same day.

11 6MASHdoc_SA, GenomicsKate, Dr.ObesityMed and 8 others
Reply Quote Save Share Report
newstart_MO
New Member
12
45
Feb 2026
Springfield, MO
May 1, 2026 at 3:36 AM#5

From the other side of the consultation, briefly. The mechanism and the magnitude are separate questions. Agreeing that something happens says nothing about whether it happens enough to act on.

10 5RunnerRach, TrialNerd_Beth, HPLC_Greg and 7 others
Reply Quote Save Share Report
1236

Similar Threads

Nausea incidence by dose tier — STEP and SURMOUNT meta-analysis16 replies
Constipation on GLP-1: pathophysiology and fiber protocol5 replies
Alopecia on GLP-1 — telogen effluvium differential diagnosis3 replies
Gallbladder disease risk — cholelithiasis data from clinical trials12 replies
Pancreatitis risk assessment — pooled safety analysis15 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register